OrthoPediatrics Q1 revenue up 13% to $59.4M; lifts FY2026 guidance to $263-267M

ORTHOPEDIATRICS CORP

2026-Q1 EPS reported -$0.45 revenue$59,362,000

Revenue $59.4M (13% YoY); US +11%, International +22%; Trauma & Deformity +14%, Scoliosis +13%.
Adjusted EBITDA of $2.2M vs. -$0.4M in Q1 2025; net loss unchanged at $10.7M (-$0.45 EPS).
Free cash flow usage improved 40% to -$5.0M from -$8.4M.
FY2026 revenue guidance raised to $263-267M (prior $262-266M); adj. EBITDA reiterated ~$25M.
Cash & equivalents $50.9M (down from $62.9M at Dec 31, 2025).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ORTHOPEDIATRICS CORP reported the first quarter ended March 31, 2026 results: revenue $59.4 million, net income Net loss for the first quarter of 2026 was $10.7 million, EPS $0.45 per basic and diluted share. Guidance raised.

Period: the first quarter ended March 31, 2026
Revenue: $59.4 million
Net income: Net loss for the first quarter of 2026 was $10.7 million
EPS: $0.45 per basic and diluted share
Guidance: raised
Result: reported results

Exact text from the filing

quarter ended March 31, 2026. First Quarter 2026 and Business Highlights • Helped a record of over 45,000 children in the first quarter of 2026 • Generated total revenue of $59.4 million for the first quarter of 2026, up 13% from $52.4 million in the first quarter of 2025; domestic revenue increased 11% and international revenue increased 22% in the quarter •

View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

ORTHOPEDIATRICS CORP filing history →

Source: SEC EDGAR

accession 0001425450-26-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.